Vulture: VULnerabilities in impuTing drUg REsistance
Article No.: 56, Pages 1 - 6
Abstract
Drug resistance is the drop in the effectiveness of a medication over time, and has severe consequences for cancer patients, as the use of incorrect drugs from the onset of the disorder not only wastes valuable treatment time for the rapidly advancing cancer types but also weakens the natural defense mechanism of the patients. The high cost of wet-lab experiments necessitates cheap computational methods for drug resistance prediction. Although many different approaches have been developed over the years to perform drug response prediction, few studies focus on the reliability of these predictions. In this paper, we develop the first framework, named VultuRe (VULnerabilities in impuTing drUg REsistance), to identify the vulnerabilities in drug resistance prediction. Our results demonstrate that the success of drug resistance imputation might be different for each drug and VultuRe efficiently detects the vulnerabilities in drug response imputation, suggesting alternatives to overcome wrong predictions.
References
[1]
Mohsen Arzanlou, Wern Chern Chai, and Henrietta Venter. 2017. Intrinsic, adaptive and acquired antimicrobial resistance in gram-negative bacteria. Essays in biochemistry, 61 1, 49--59.
[2]
Jonathan I. Batchelder, Patricia J. Hare, and Wendy W. K. Mok. 2023. Resistance-resistant antibacterial treatment strategies. Frontiers in antibiotics, 2.
[3]
Jessica M. A. Blair, Mark A. Webber, Alison J. Baylay, David Olusoga Ogbolu, and Laura J. V. Piddock. 2014. Molecular mechanisms of antibiotic resistance. Nature Reviews Microbiology, 13, 42--51.
[4]
Aysegul Bumin, Anna Ritz, Donna Slonim, Tamer Kahveci, and Kejun Huang. 2022. FiT: fiber-based tensor completion for drug repurposing. In ACM International Conference on Bioinformatics, 1--10.
[5]
Emmanuel J Candes and Yaniv Plan. 2010. Matrix completion with noise. Proceedings of the IEEE, 98, 6, 925--936.
[6]
Elizabeth M. Darby, Eleftheria Trampari, Pauline Siasat, Maria Solsona Gaya, Ilyas Alav, Mark A. Webber, and Jessica M. A. Blair. 2022. Molecular mechanisms of antibiotic resistance revisited. Nature reviews. Microbiology.
[7]
Paul Geeleher, Nancy J Cox, and R Stephanie Huang. 2014. Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome biology, 15, 1--12.
[8]
Graham F. Hatfull, Rebekah M. Dedrick, and Robert T. Schooley. 2021. Phage therapy for antibiotic-resistant bacterial infections. Annual review of medicine.
[9]
Nicole C. Howard et al. 2018. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes. Nature microbiology, 3, 1099--1108.
[10]
Mortaza Jamshidian and Peter M Bentler. 1999. Ml estimation of mean and covariance structures with missing data using complete data routines. Journal of Educational and behavioral Statistics, 24, 1, 21--24.
[11]
Peilin Jia, Ruifeng Hu, Guangsheng Pei, Yulin Dai, Yin-Ying Wang, and Zhongming Zhao. 2021. Deep generative neural network for accurate drug response imputation. Nature Communications, 12, 1, 1740.
[12]
Aanchal Kashyap, Pankaj Kumar Singh, and Om Silakari. 2018. Mechanistic investigation of resistance via drug-inactivating enzymes in mycobacterium tuberculosis. Drug Metabolism Reviews, 50, 4, 448--465. 30343607.
[13]
Peter Lambert. 2005. Bacterial resistance to antibiotics: modified target sites. Advanced drug delivery reviews, 57, (Aug. 2005), 1471--85.
[14]
Kerstin Lenhof, Nico Gerstner, Tim Kehl, Lea Eckhart, Lara Schneider, and Hans-Peter Lenhof. 2021. Merida: a novel boolean logic-based integer linear program for personalized cancer therapy. Bioinformatics, 37, 21, 3881--3888.
[15]
Yuan Liu, Ruichao Li, Xia Xiao, and Zhiqiang Wang. 2018. Molecules that inhibit bacterial resistance enzymes. Molecules, 24.
[16]
Avantika Mann, Kiran Nehra, J.S. Rana, and Twinkle Dahiya. 2021. Antibiotic resistance in agriculture: perspectives on upcoming strategies to overcome upsurge in resistance. Current Research in Microbial Sciences, 2, 100030.
[17]
Marcelo Beltrão Molento. 2009. Parasite control in the age of drug resistance and changing agricultural practices. Veterinary Parasitology, 163, 3, 229--234. One World, One Health: Parasites in a changing landscape.
[18]
Wei Peng, Tielin Chen, and Wei Dai. 2021. Predicting drug response based on multi-omics fusion and graph convolution. IEEE Journal of Biomedical and Health Informatics, 26, 3, 1384--1393.
[19]
Yidi Qu, Bo Dou, Hor-Yue Tan, Yibin Feng, Ning Wang, and Di Wang. 2019. Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment. Molecular Cancer, 18.
[20]
Wanda C Reygaert. 2018. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiology, 4, 482--501.
[21]
Diana Sapashnik et al. 2023. Cell-specific imputation of drug connectivity mapping with incomplete data. Plos one, 18, 2, e0278289.
[22]
Hossein Sharifi-Noghabi, Olga Zolotareva, Colin C Collins, and Martin Ester. 2019. MOLI: multi-omics late integration with deep neural networks for drug response prediction. Bioinformatics, 35, 14, i501--i509.
[23]
Xin-zhuan Su, Jian Wu, Fangzheng Xu, and Sittiporn Pattaradilokrat. 2022. Genetic mapping of determinants in drug resistance, virulence, disease susceptibility, and interaction of host-rodent malaria parasites. Parasitology international, 102637.
[24]
Yifei Sun, Mahmood Zabihi, Qi Li, Xiaosi Li, Brandon Kim, Eroboghene Ubogu, Srinivasa Raja, Ursula Wesselmann, and Chao Zhao. 2023. Drug permeability: from the blood-brain barrier to the peripheral nerve barriers. Advanced Therapeutics, (Jan. 2023), 2200150.
[25]
Tanya Verma, Anchal Aggarwal, Shikha Singh, Sumit Sharma, and Saurabh Jyoti Sarma. 2021. Current challenges and advancements towards discovery and resistance of antibiotics. Journal of Molecular Structure.
[26]
Lin Wang, Xiaozhong Li, Louxin Zhang, and Qiang Gao. 2017. Improved anti-cancer drug response prediction in cell lines using matrix factorization with similarity regularization. BMC cancer, 17, 1, 1--12.
[27]
Peike Wu et al. 2023. DROEG: a method for cancer drug response prediction based on omics and essential genes integration. Briefings in Bioinformatics, 24.
[28]
Shunyu Xiang et al. 2019. A dual-action pesticide carrier that continuously induces plant resistance enhances plant anti-tmv activity of plant and promotes plant growth. Journal of agricultural and food chemistry.
[29]
Wanjuan Yang et al. 2012. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic acids research, 41, D1, D955--D961.
[30]
Fei Zhang, Minghui Wang, Jianing Xi, Jianghong Yang, and Ao Li. 2018. A novel heterogeneous network-based method for drug response prediction in cancer cell lines. Scientific reports, 8, 1, 1--9.
Index Terms
- Vulture: VULnerabilities in impuTing drUg REsistance
Recommendations
Computational study to understand mechanism of isoniazid drug resistance caused by mutation (R268H) in NADH dehydrogenase of Mycobacterium tuberculosis
NADH dehydrogenase (Ndh) of Mycobacterium tuberculosis is essential for conversion of NADH to NAD+ in the presence of FMN. An increased NADH/NAD+ ratio was reported due to mutation (R268H) in Ndh, causing INH resistance. To study the effect of this ...
Dissecting the role of ALK double mutations in drug resistance to lorlatinib with in-depth theoretical modeling and analysis
AbstractAnaplastic lymphoma kinase (ALK) is implicated in the genesis of multiple malignant tumors. Lorlatinib stands out as the most advanced and effective inhibitor currently used in the clinic for the treatment of ALK-positive non-small cell lung ...
Highlights- We elucidate the resistance mechanisms of lorlatinib against ALK double mutations.
- Investigating the dissociation paths of lorlatinib in both wild-type and mutant ALK provides crucial insights.
- Residues Leu1256, Glu1197, and ...
Structural dynamics and kinase inhibitory activity of three generations of tyrosine kinase inhibitors against wild-type, L858R/T790M, and L858R/T790M/C797S forms of EGFR
AbstractMutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR), including L858R/T790M double and L858R/T790M/C797S triple mutations, are major causes of acquired resistance towards EGFR targeted drugs. In this work, a ...
Graphical abstractDisplay Omitted
Comments
Please enable JavaScript to view thecomments powered by Disqus.Information & Contributors
Information
Published In
September 2023
626 pages
Copyright © 2023 ACM.
Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected].
Sponsors
Publisher
Association for Computing Machinery
New York, NY, United States
Publication History
Published: 04 October 2023
Check for updates
Author Tags
Qualifiers
- Research-article
Funding Sources
- NSF
Conference
BCB '23
Sponsor:
BCB '23: 14th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics
September 3 - 6, 2023
TX, Houston, USA
Acceptance Rates
Overall Acceptance Rate 254 of 885 submissions, 29%
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 63Total Downloads
- Downloads (Last 12 months)49
- Downloads (Last 6 weeks)14
Reflects downloads up to 24 Nov 2024
Other Metrics
Citations
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign in